These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18604175)

  • 1. Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma.
    Strizzi L; Abbott DE; Salomon DS; Hendrix MJ
    Cell Cycle; 2008 Jul; 7(13):1931-5. PubMed ID: 18604175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Cripto-1 in stem cell maintenance and malignant progression.
    Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
    Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling.
    Shi S; Ge C; Luo Y; Hou X; Haltiwanger RS; Stanley P
    J Biol Chem; 2007 Jul; 282(28):20133-41. PubMed ID: 17504756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
    Kelber JA; Shani G; Booker EC; Vale WW; Gray PC
    J Biol Chem; 2008 Feb; 283(8):4490-500. PubMed ID: 18089557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of a Cripto-1 positive subpopulation of human melanoma cells exhibiting stem cell-like characteristics.
    Strizzi L; Margaryan NV; Gilgur A; Hardy KM; Normanno N; Salomon DS; Hendrix MJ
    Cell Cycle; 2013 May; 12(9):1450-6. PubMed ID: 23574716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
    Gray PC; Shani G; Aung K; Kelber J; Vale W
    Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells.
    Watanabe K; Meyer MJ; Strizzi L; Lee JM; Gonzales M; Bianco C; Nagaoka T; Farid SS; Margaryan N; Hendrix MJ; Vonderhaar BK; Salomon DS
    Stem Cells; 2010 Aug; 28(8):1303-14. PubMed ID: 20549704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
    Kelber JA; Panopoulos AD; Shani G; Booker EC; Belmonte JC; Vale WW; Gray PC
    Oncogene; 2009 Jun; 28(24):2324-36. PubMed ID: 19421146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
    Yan YT; Liu JJ; Luo Y; E C; Haltiwanger RS; Abate-Shen C; Shen MM
    Mol Cell Biol; 2002 Jul; 22(13):4439-49. PubMed ID: 12052855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.
    Alam MJ; Takahashi R; Afify SM; Oo AKK; Kumon K; Nawara HM; Khayrani AC; Du J; Zahra MH; Seno A; Salomon DS; Seno M
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
    J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.
    Wouters J; Stas M; Gremeaux L; Govaere O; Van den Broeck A; Maes H; Agostinis P; Roskams T; van den Oord JJ; Vankelecom H
    PLoS One; 2013; 8(10):e76550. PubMed ID: 24098529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.
    Taghizadeh R; Noh M; Huh YH; Ciusani E; Sigalotti L; Maio M; Arosio B; Nicotra MR; Natali P; Sherley JL; La Porta CA
    PLoS One; 2010 Dec; 5(12):e15183. PubMed ID: 21203549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD271 is an imperfect marker for melanoma initiating cells.
    Cheli Y; Bonnazi VF; Jacquel A; Allegra M; De Donatis GM; Bahadoran P; Bertolotto C; Ballotti R
    Oncotarget; 2014 Jul; 5(14):5272-83. PubMed ID: 25105565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L; Bianco C; Normanno N; Salomon D
    Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ cell nuclear factor is a repressor of CRIPTO-1 and CRIPTO-3.
    Hentschke M; Kurth I; Borgmeyer U; Hübner CA
    J Biol Chem; 2006 Nov; 281(44):33497-504. PubMed ID: 16954206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal/Cripto signaling in fetal male germ cell development: implications for testicular germ cell tumors.
    Spiller CM; Bowles J; Koopman P
    Int J Dev Biol; 2013; 57(2-4):211-9. PubMed ID: 23784832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction.
    D'Andrea D; Liguori GL; Le Good JA; Lonardo E; Andersson O; Constam DB; Persico MG; Minchiotti G
    J Cell Biol; 2008 Feb; 180(3):597-605. PubMed ID: 18268105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.